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Abstract
Background: Relapse in individuals with severe mental illness (SMI) is a frequent occurrence and can add
considerably to the burden of disease. As such, relapse prevention is an essential therapeutic outcome for people
with SMI. Mental health nurses (MHNs) are well placed to support individuals with SMI and to prevent relapse;
notwithstanding, there has been no synthesis of the evidence to date to determine whether MHNs prevent relapse
in this population.
Methods: Electronic databases will be systemically searched for observational studies and clinical trials that report
the association between mental health nursing and the hospitalisation of persons living with an SMI. The search
will be supplemented by reference checking and a search of the grey literature. The primary outcome of interest
will be hospital admission rate. Screening of articles, data extraction and critical appraisal will be undertaken by two
reviewers, independently, with a third reviewer consulted should disagreement occur between reviewers. The
quality of studies will be assessed using the Risk Of Bias In Non-randomised Studies - of Interventions (ROBINS-I)
tool and the Cochrane Collaboration risk of bias tool. Depending on the number of studies and level of
heterogeneity, the evidence may be synthesised using meta-analysis or narrative synthesis.
Discussion: This review will explore for the first time the clinical potential of mental health nursing in preventing
relapse in persons with SMI. The findings of this review will serve to inform future research and education in this
area. The evidence may also help inform future policy, including decisions regarding future mental health workforce
development and planning.
Systematic review registration: PROSPERO CRD42017058694.
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Background
Mental disorders represent a highly prevalent and burden-
some group of diagnosable health conditions. Across the
globe, close to one in three people (29%) have experienced
a common mental disorder some point in their lifetime
[1]. The burden of these disorders is considerable,
accounting for 183.9 million disability-adjusted life years
(DALYs) or 7.4% of all DALYs worldwide. More than 14%
of the DALYs caused by mental and substance use
disorders are in people with severe mental illness [2].
Serious mental illness (SMI) is a diagnosis of any non-
organic psychosis, with a duration of treatment of 2 years
or more, and evidence of dysfunction (as measured by
the Global Assessment of Functioning scale) [3]. Condi-
tions captured within SMI include schizophrenia,
schizophrenia-like disorders, bipolar disorder and
depression with psychotic features [4]. People with SMI
are a particularly vulnerable group, with reports of
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increased risk of criminal victimisation (2.3 to 140-fold
increased risk) [5], hospitalisation [6], falls [6], emer-
gency department presentations (2.9-fold increased risk)
[7] and mortality (2.2-fold increased risk) [4] when com-
pared with the general population.
Relapse (i.e. the worsening of psychopathological
symptoms or re-hospitalisation within 12 months of dis-
charge from hospital) [8] in people with SMI is a fre-
quent occurrence. Approximately 20% of individuals
with schizophrenia will relapse [9]; for people with bipo-
lar disorder, the rate of relapse may be as high as 40%
[10]. A high proportion of relapses (i.e. 75% of cases) in
people with schizophrenia result in admission to hospital
[8]; this adds considerably to health care expenditure
and further burdens health care resources [9]. Relapse
(and subsequent hospitalisation) is also distressing for
the person with SMI and their family [11]. Furthermore,
a relapse experience in persons living with serious men-
tal illness increases the likelihood of further relapse [9].
It is no surprise then that relapse prevention is a key
therapeutic aim of SMI [12].
Case management is a comprehensive approach to
managing serious mental illness, with evidence suggest-
ing that intensive case management may be effective in
reducing hospitalisation in people with SMI [13]. Mental
health nurses (MHNs) account for a considerable pro-
portion of case managers; they also represent the great-
est percentage of the mental health workforce [14].
Consequently, MHNs are likely to have the largest face-
to-face time with people living with SMI than any other
discipline [15]. As such, MHNs are well placed in their
role to support people with SMI and to prevent relapse.
Despite the broad implications of relapse in people with
SMI and the assumed role of MHNs in mitigating admis-
sions to hospital in this population, there has been no
synthesis of the evidence to ascertain whether MHNs can
prevent relapse in people with SMI. This systematic
review addresses this knowledge gap by investigating the
relationship between MHN exposure and hospitalisation-
related outcomes in individuals with SMI.
Methods
Research objectives
The aim of this review will be to systematically review,
appraise and synthesise the evidence from studies
reporting the association between mental health nursing
and the hospitalisation of persons living with SMI.
Eligibility criteria
Study designs
The review will consider published and unpublished
observational studies (including cross-sectional, cohort
and case-control studies) and clinical trials (including
randomised controlled trials, non-randomised controlled
trials and comparative studies) that address the research
objective. Excluded will be qualitative investigations and
literature reviews.
Participants
Participants will be limited to community-dwelling
people diagnosed with SMI, which includes schizophre-
nia, schizophrenia-like disorders, bipolar disorder and
depression with psychotic features [4]. Excluded will be
persons living in secure settings and hospital inpatients.
Interventions
Studies that examine the effect of care provided by mental
health nurses only will be eligible for inclusion. For the
purpose of this review, a mental health or psychiatric
nurse is someone who has completed a formal qualifica-
tion in mental health/psychiatric nursing and has been
credentialed, licensed or registered to practice in that
capacity (e.g. registered psychiatric nurse). Studies exam-
ining the effect of team-based models of care, or specific
MHN-administered clinical interventions (e.g. cognitive
behavioural therapy, adherence therapy), will be excluded.
Comparators
The review will consider any comparison, including
other health service providers (e.g. psychologists, psychi-
atrists), team-based models of care, non-MHN exposure
and services provided by non-government organisations.
Outcomes
The review focuses on parameters related to hospitalisa-
tion and safety, as outlined below.
Primary outcomes
– Hospital admission rate (e.g. 30-day admission rate)
Secondary outcomes
– Hospital length of stay (e.g. mean number of
hospital bed days)
– Emergency department (ED) presentations (e.g.
mean number of ED presentations, proportion of ED
presentations resulting in hospital admission)
– Home treatment/crisis team presentations (e.g. team
referrals and admissions)
– Number of days treated by home treatment/crisis
teams
– Admissions to and number of days in crisis houses
– Detention in hospital under mental health law
– Adverse events (e.g. complications, mortality)
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Search strategy
Eligible studies will be identified using the following search
terms (the example provided applies to the MEDLINE
database, with ‘ti,ab’ meaning title and abstract, ‘sh’ meaning
subject heading and ‘pt’ meaning publication type):
i. Mental health nurs$.ti,ab. OR psychiatric nursing.sh.
OR psychiatric nurs$.ti,ab.
ii. Severe mental illness.ti,ab. OR mental disorder.sh.
OR mental illness.ti,ab. OR schizo$.ti,ab. OR
schizophrenia.sh. OR bipolar disorder.sh. OR
psychos?s.ti,ab. OR psychotic.ti,ab. OR psychotic
disorders.sh. OR psychotic affective disorders.sh. OR
disorders with psychotic features.ti,ab. OR psychotic
depression.ti,ab.
iii. Patient admission.sh. OR patient readmission.sh.
OR hospital admission.ti,ab. OR hospital
readmission.ti,ab. OR unplanned readmission.ti,ab.
OR hospitalization.sh. OR readmission rate.ti,ab.
OR length of stay.sh. OR emergency department
presentation.ti,ab. OR admission to home
treatment.ti,ab. OR access to crisis
intervention.ti,ab. OR drop-in treatment.ti,ab. OR
drop-in care.ti,ab. OR drop-in unit.ti,ab. OR drop-
in centre.ti,ab. OR home intervention.ti,ab. OR
home therapy.ti,ab. OR home care.ti,ab. OR home
management.ti,ab.
iv. Observational study.pt. OR cross-sectional study.pt.
OR cohort study.pt. OR longitudinal study.pt. OR
epidemiologic study.pt. OR case-control study.pt. OR
controlled clinical trial.pt. OR randomized controlled
trial.pt. OR non-randomised controlled trial.pt. OR
quasi-experimental study.pt. OR clinical trial.pt. OR
comparative study.pt.
The search will only include articles published in the
English language. No restrictions on the date of publica-
tion will be applied to the searches.
The search will be conducted using the following elec-
tronic databases, from their inception:
– EMBASE [OVID]
– CINAHL [EbscoHost]
– Health Source: Nursing/Academic Edition
[EbscoHost]
– MEDLINE [OVID]
– Nursing & Allied Health Database [ProQuest]
– Ovid Nursing [Ovid]
– ProQuest Dissertations and Theses Global
[ProQuest]
– PsychINFO [Ovid]
– PubMed [NCBI]
– The Cochrane Library
– Web of Science [Thomson Reuters]
Also, the reference lists of included studies will be hand-
searched to identify potentially eligible studies. Trial regis-
ters also will be searched to identify on-going or unpub-
lished trials, including http://www.ClinicalTrials.gov, http://
www.who.int/trialsearch/ and http://www.anzctr.org.au/.
Study selection
Records identified in the searches will be exported to
reference management software (Endnote). Duplicate
records will be reviewed, and if appropriate, excluded. The
reference management file will be exported to Covidence
(a web-based software platform for systematic reviews) for
screening. Titles and abstracts of all identified articles will
be screened for eligibility against the review selection cri-
teria. Two reviewers (KM, AJ) will conduct the screening
process, independently. Discussions will occur with a third
reviewer if disagreements occur (RG). The same process
will be followed at the full-text screening stage of the
review. A PRISMA (Preferred Reporting Items for System-
atic Reviews and Meta-analyses) flow chart will be com-
piled to summarise the study selection process.
Data extraction
Data from eligible studies will be extracted using a data
extraction tool developed exclusively for this review. The
Covidence platform will be utilised to administer the
study. The tool will collect information on several differ-
ent parameters. This will include study/report character-
istics (i.e. author, year of publication, country), research
methodology (i.e. study design, number of study
centers), participants (i.e. sample size, sampling frame,
selection criteria, setting, demographic and clinical char-
acteristics of participants), interventions (i.e. detailed
description of intervention[s], level of exposure), com-
parators (i.e. detailed description of comparator[s], level
of exposure), outcomes (i.e. primary and secondary out-
comes, outcome measures), results (i.e. findings reported
against each outcome) and new references (i.e. identifi-
cation of potentially eligible studies). Data extraction will
be performed by two reviewers (KM, AJ), independently,
with disagreements resolved by discussion with a third
reviewer (ML).
Risk of bias
The risk of bias of observational studies will be assessed
using the Risk Of Bias In Non-randomised Studies - of
Interventions (ROBINS-I) tool [16]; this will be adminis-
tered via the Covidence platform. The ROBINS-I tool
evaluates the risk of bias across seven distinct domains,
including baseline and time-varying confounding,
participant selection, intervention classification, co-
intervention, missing data, outcome measurement and
selective reporting bias. Two reviewers (MJ, ML) will
independently evaluate the risk of bias and rate studies
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as having low, moderate, severe, critical or unclear risk
of bias. If a disagreement occurs between reviewers, a
third reviewer will be consulted (DB).
The risk of bias of clinical trials will be evaluated using
the Cochrane Collaboration risk of bias tool [17]. The
Cochrane tool assesses risk across seven domains,
including sequence generation, allocation concealment,
blinding of participants, personnel and outcome asses-
sors, incomplete outcome data, selective outcome
reporting and other sources of bias. Two reviewers (MJ,
ML) will independently assign a judgement related to
the risk of bias for each item, with a judgement of ‘Yes’
indicating low risk of bias, ‘No’ indicating a high risk of
bias and ‘Unclear’ indicating unclear or unknown risk of
bias. If consensus cannot be achieved between the two
reviewers, a third reviewer will arbitrate (DB).
Data synthesis
Where there are three or more studies that report simi-
lar designs, interventions and outcome measures, data
will be combined by way of meta-analysis to calculate
pooled effect estimates and their 95% confidence inter-
vals using a random-effects model. This analysis will be
conducted using Review Manager software (RevMan,
version 5.3, Copenhagen, The Nordic Cochrane Centre,
The Cochrane Collaboration, 2017). In the event of sub-
stantial statistical (I2 ≥ 50%), clinical or methodological
heterogeneity, or where there are too few studies, results
will be presented using a systematic narrative synthesis.
Two reviewers (ML/MJ) will undertake the synthesis.
Disagreement between reviewers will be resolved via
discussion with a third reviewer (RG).
Subgroup analyses will be performed to explore the
influence of nurses’ clinical practice setting (community,
outpatient, inpatient, country), highest mental health
qualification (diploma, master’s, PhD), psychosocial
intervention training (e.g. cognitive behavioural therapy)
and years of mental health nursing experience (< 5 years,
6–10 years, > 10 years). Similarly, sensitivity analyses will
be undertaken to determine whether the outcomes of
the study are affected by risk of bias (i.e. excluding from
the analysis any studies judged as having severe/critical/
unclear risk of bias).
Risk of bias across studies
Where there are at least ten studies included in a meta-
analysis, funnel plot asymmetry will be tested in order to
assess the presence of publication bias and small study
effects. The Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach will be
used to judge the quality of evidence for all outcomes
[18]. This approach rates the quality of the body of evi-
dence by considering the following aspects: study design,
risk of bias, imprecision, inconsistency, indirectness and
magnitude or effect. The quality of the evidence will be
rated as either high, moderate, low or very low.
Discussion
Relapse is common in people with SMI. The implica-
tions of relapse are considerable, impacting not only
patients and their carers but also the mental health
workforce and policy makers. Prevention of relapse or
maintaining an optimum level of well-being is an
important objective of mental health care and a core
skill of mental health nurses.
It is acknowledged that relapse in people with SMI can
be difficult to measure. Some people with SMI are
admitted to hospital for reasons other than relapse, such
as the initiation of clozapine treatment. There are also
instances when people with SMI relapse that do not go
into hospital (Schennach et al. [8]); in such cases, the
person may be cared for at home by a crisis resolution
or home treatment team. Nonetheless, given that the
majority of cases of relapse in SMI result in hospital ad-
mission (Schennach et al. [8]) and hospitalisation is asso-
ciated with considerable psychosocial and economic
burden (Ascher-Svanum et al. [10]; Gerson & Rose [11]),
admission to hospital is considered a suitable proxy
measure of relapse; accordingly, hospital admission is
likely to be an important indicator of the effectiveness of
mental health nursing in preventing people with SMI
from experiencing a relapse.
Mental health nurses arguably play an important func-
tion in building relationships, providing social support
(such as help with housing, access to employment and
education opportunities) and facilitating the safe admin-
istration of medications (Department of Health [15]).
However, on a hierarchy of MHN clinical outcomes, pre-
venting relapse should be a key therapeutic aim of SMI
(Olivares et al. [12]); it is also perhaps the most signifi-
cant and most meaningful outcome for patients, particu-
larly when the consequences of relapse are taken into
consideration. Relapse is also costly, and therefore, it
should be an important consideration for policy makers
in any future health workforce planning.
This review is timely for mental health nursing, with
recent findings from a large multi-national observational
study demonstrating the impact of nurse educational
qualifications on patient mortality; specifically, the asso-
ciation between the provision of care by bachelor degree
qualified nurses and increased probability of survival in
a general hospital setting (Aitken et al. [19]). Of course,
this work only examined medical-surgical nurses and
further work needs to be done to determine whether a
qualification in mental health nursing impacts health
outcomes in patients with SMI (recognising that MHN
training programs vary across countries and any future
work in this area will need to take into consideration
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differences in the educational preparation of MHNs). As
a first step in addressing this knowledge gap, this review
will explore the clinical potential of mental health
nursing in preventing relapse in individuals with SMI.
The findings will help to inform future policy, research
and education in this area; it may also assist decision
makers with future mental health workforce develop-
ment and planning.
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